Chemical and Allied Products Plc (NGX:CAP)
Nigeria · Delayed Price · Currency is NGN 159.70
+14.50 (9.99%)
At close: May 4, 2026
NGX:CAP Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46,358 | 44,855 | 36,362 | 23,890 | 19,208 | 14,208 | |
Revenue Growth (YoY) | 22.17% | 23.36% | 52.20% | 24.37% | 35.20% | 60.07% |
Cost of Revenue | 27,070 | 26,247 | 22,126 | 15,131 | 11,684 | 9,650 |
Gross Profit | 19,288 | 18,608 | 14,236 | 8,759 | 7,524 | 4,558 |
Selling, General & Admin | 11,041 | 10,934 | 9,168 | 6,072 | 4,706 | 3,342 |
Other Operating Expenses | -505.37 | -472.31 | -395.27 | -486.74 | -244.74 | -134.92 |
Operating Expenses | 10,612 | 10,539 | 8,828 | 5,553 | 4,430 | 3,244 |
Operating Income | 8,676 | 8,069 | 5,408 | 3,206 | 3,095 | 1,314 |
Interest Expense | -36.77 | -1.45 | -30.13 | -155.35 | -33.55 | -7.61 |
Interest & Investment Income | 1,049 | 1,049 | 184.45 | 311.7 | 174.31 | 180.48 |
Currency Exchange Gain (Loss) | 20.35 | 20.35 | 460.32 | 369.55 | 207.46 | 76.11 |
Other Non Operating Income (Expenses) | 108.71 | - | - | - | - | - |
EBT Excluding Unusual Items | 9,818 | 9,138 | 6,023 | 3,732 | 3,443 | 1,563 |
Gain (Loss) on Sale of Assets | - | - | 41.55 | 46.58 | 6.47 | 164.27 |
Asset Writedown | - | - | - | - | -5.02 | - |
Pretax Income | 9,818 | 9,138 | 6,064 | 3,779 | 3,444 | 1,727 |
Income Tax Expense | 3,641 | 3,393 | 2,257 | 1,264 | 1,068 | 604.92 |
Net Income | 6,176 | 5,745 | 3,807 | 2,515 | 2,376 | 1,123 |
Net Income to Common | 6,176 | 5,745 | 3,807 | 2,515 | 2,376 | 1,123 |
Net Income Growth | 67.86% | 50.89% | 51.40% | 5.83% | 111.67% | -8.22% |
Shares Outstanding (Basic) | 815 | 815 | 815 | 815 | 815 | 788 |
Shares Outstanding (Diluted) | 815 | 815 | 815 | 815 | 815 | 788 |
Shares Change (YoY) | 0.04% | - | - | - | 3.36% | 12.61% |
EPS (Basic) | 7.58 | 7.05 | 4.67 | 3.09 | 2.92 | 1.42 |
EPS (Diluted) | 7.58 | 7.05 | 4.67 | 3.09 | 2.92 | 1.42 |
EPS Growth | 67.77% | 50.96% | 51.30% | 5.83% | 104.79% | -18.50% |
Free Cash Flow | 7,502 | 6,802 | 3,170 | 2,868 | 635.85 | -1,893 |
Free Cash Flow Per Share | 9.21 | 8.35 | 3.89 | 3.52 | 0.78 | -2.40 |
Dividend Per Share | 4.000 | 4.000 | 2.400 | 1.550 | 1.550 | 1.250 |
Dividend Growth | 66.67% | 66.67% | 54.84% | - | 24.00% | -40.48% |
Gross Margin | 41.61% | 41.48% | 39.15% | 36.66% | 39.17% | 32.08% |
Operating Margin | 18.71% | 17.99% | 14.87% | 13.42% | 16.11% | 9.25% |
Profit Margin | 13.32% | 12.81% | 10.47% | 10.53% | 12.37% | 7.90% |
Free Cash Flow Margin | 16.18% | 15.17% | 8.72% | 12.01% | 3.31% | -13.33% |
EBITDA | 9,461 | 8,822 | 6,063 | 3,625 | 3,448 | 1,539 |
EBITDA Margin | 20.41% | 19.67% | 16.68% | 15.17% | 17.95% | 10.84% |
D&A For EBITDA | 784.86 | 752.11 | 655.24 | 418.58 | 353.88 | 225.1 |
EBIT | 8,676 | 8,069 | 5,408 | 3,206 | 3,095 | 1,314 |
EBIT Margin | 18.71% | 17.99% | 14.87% | 13.42% | 16.11% | 9.25% |
Effective Tax Rate | 37.09% | 37.13% | 37.22% | 33.45% | 31.01% | 35.02% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.